NL-OMON38610
Withdrawn
Not Applicable
Validation of the 'Suicidality: Treatment Occuring in Paediatrics (STOP) Suite of Measures' in Clinical and Non-clinical Child and Adolescent Populations - STOP study
niversitair Medisch Centrum Sint Radboud0 sites250 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Psychiatric disorder
- Sponsor
- niversitair Medisch Centrum Sint Radboud
- Enrollment
- 250
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children and adolescents between the ages of 8 and 18 years old, and their parents or main carer.
- •Children and adolescents newly treated with an antidepressant or cognitive behavior therapy for depression or antipsychotic medication for any indication (this inclusion criteria is for clinical population only).
- •All parents and patients have provided informed consent/assent in accordance with ethical regulations.
Exclusion Criteria
- •If the main carer does not have a reasonable level of Dutch, they will be excluded from the study. This is because a reasonable level of Dutch is required to complete the baseline information.
- •Children who are deemed by the clinician to be too vulnerable to participate (for clinical population only).
- •The child/adolescent will be excluded if the main carer is not available to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
VECTORS – A study to evaluate transmural healing as a treatment target in Crohn’s diseaseModerately to Severely Active Crohn’s DiseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]CTIS2023-509096-16-00Alimentiv Inc.266
Recruiting
Phase 2
A Clinical Trial To Evaluate The Effectiveness Of Vasa Avaleha In Respiratory Symptoms As A Sequelae Of FeverCTRI/2023/07/055016I
Recruiting
Phase 2
A Clinical Trial To Evaluate The Action OF Duralabhadi Decoction In The Management Of Urinary Tract Infections.CTRI/2023/07/055121I
Not yet recruiting
Phase 2
A clinical study to see the effectiveness of medicated oil administration through nose on nasal flora of healthy individualsCTRI/2023/07/055213Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Not yet recruiting
Phase 3
Effectiveness of Homoeopathic Medicine in treating Inflammatory Bowel DiseaseHealth Condition 1: K50- Crohns disease [regional enteritis]Health Condition 2: K51- Ulcerative colitisCTRI/2022/03/040881Anju KS